Safety and immunogenicity of a SARS-CoV-2 inactivated vaccine in patients with chronic hepatitis B virus infection

Detalles Bibliográficos
Autores principales: Xiang, Tiandan, Liang, Boyun, Wang, Hua, Quan, Xufeng, He, Shengsong, Zhou, Helong, He, Yongwen, Yang, Dongliang, Wang, Baoju, Zheng, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591435/
https://www.ncbi.nlm.nih.gov/pubmed/34782756
http://dx.doi.org/10.1038/s41423-021-00795-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591435/
https://www.ncbi.nlm.nih.gov/pubmed/34782756
http://dx.doi.org/10.1038/s41423-021-00795-5

Ejemplares similares